Medical News

RSS

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).

13 Oct 2010

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).

13 Oct 2010

Urgent Care Association of America certifies eighteen more facilities

Eighteen more facilities have just received the Certified Urgent Care Center designation awarded by the Urgent Care Association of America. The Certified Urgent Care program helps the public identify urgent care centers and promotes and advances the urgent care industry.

13 Oct 2010

Global Hunger Index shows importance of addressing childhood malnutrition

The Global Hunger Index released Monday finds that many developing countries primarily in South Asia and Latin America have made significant progress in reducing hunger.

13 Oct 2010

New cancer initiative may promote rapid drug development

Greenville Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research, a visionary cancer initiative that will help pave the way for new breakthroughs in rapid drug development, diagnostic discovery and advanced cancer care. ITOR is part of the GHS Cancer Center, a recognized regional multi-disciplinary center.

13 Oct 2010

NCI rates Abramson Cancer Center as 'exceptional'

The University of Pennsylvania's Abramson Cancer Center has been rated as "exceptional" by the National Cancer Institute (NCI) during a competitive research funding review by the government agency.

13 Oct 2010

New evidence supports possible link between XMRV and prostate cancer

Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.

13 Oct 2010

USAID awards $15 million grant to Tufts University for CRSP program

Eileen T. Kennedy, DSc, Dean of the Friedman School of Nutrition Science and Policy at Tufts University announced today that the school has been awarded two grants totaling $15 million by the United States Agency for International Development (USAID). The USAID "Leader with Associates (LWA) Award" was granted to the school to serve as the Management Entity for a new Nutrition Collaborative Research Support Program (CRSP) in Africa and Asia. This is the first CRSP to be awarded by USAID in nearly 25 years.

13 Oct 2010

World Economic Forum index ranks countries by gender disparities

An index issued Tuesday by the World Economic Forum (WEF) ranked 134 countries according to how much they had reduced gender disparities over the past year in the areas of economic participation, education, political empowerment and health, the New York Times reports.

13 Oct 2010

SAMHSA awards State Incentive Grants for substance abuse prevention

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.

13 Oct 2010

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study in the current issue of the American Journal of Epidemiology.

13 Oct 2010

Some states snub health reform; in others, election will decide fate of law's implementation

Politico reports that races at the state level could affect the health law more than congressional races. Governors who oppose the legislation can refuse to set up pieces of the law, such as the state-based insurance exchanges where most Americans will purchase coverage beginning in 2014.

13 Oct 2010

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

A pregnant woman's immune response to viral infections may induce subtle neurological changes in the unborn child that can lead to an increased risk for neurodevelopmental disorders including schizophrenia and autism. Research published in the online journal mBio- provides new insights into how this may happen and suggests potential strategies for reducing this risk.

13 Oct 2010

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.

13 Oct 2010

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

ERYtech Pharma is pleased to announce it has signed a collaborative research agreement with Genzyme Corporation to explore the feasibility of developing a novel therapeutic enzyme formulation using ERYtech's proprietary technology.

13 Oct 2010

Kuwait Healthy Life Study to examine metabolic health in children

In the face of a dramatic worldwide increase in adolescent obesity and Type 2 diabetes, The Forsyth Institute today announced a research alliance with the Dasman Diabetes Institute of Kuwait to initiate studies that could lay a scientific basis for prevention. This collaboration, called The Kuwait Healthy Life Study, will examine conditions in children that predispose them to obesity and Type 2 diabetes.

13 Oct 2010

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.

13 Oct 2010

Boehringer Ingelheim awards milestone payment to Xencor

Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.

13 Oct 2010

CEL-SCI receives Taiwanese IRB approval for Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.

13 Oct 2010

NHC enter agreement with Attain to offer new program for IVF fertility treatments

IntegraMed America, Inc. the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its Attain Fertility Centers division has entered into an agreement with The New Hope Center for Reproductive Medicine (NHC) to begin offering the Attain IVF family of specialty financing Programs.

13 Oct 2010

Medical News

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Urgent Care Association of America certifies eighteen more facilities

Global Hunger Index shows importance of addressing childhood malnutrition

New cancer initiative may promote rapid drug development

NCI rates Abramson Cancer Center as 'exceptional'

New evidence supports possible link between XMRV and prostate cancer

USAID awards $15 million grant to Tufts University for CRSP program

World Economic Forum index ranks countries by gender disparities

SAMHSA awards State Incentive Grants for substance abuse prevention

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Some states snub health reform; in others, election will decide fate of law's implementation

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

Kuwait Healthy Life Study to examine metabolic health in children

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

Boehringer Ingelheim awards milestone payment to Xencor

CEL-SCI receives Taiwanese IRB approval for Multikine Phase III trial in head and neck cancer

NHC enter agreement with Attain to offer new program for IVF fertility treatments

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News